Publication Date
| In 2024 | 0 |
| Since 2023 | 0 |
| Since 2020 (last 5 years) | 0 |
| Since 2015 (last 10 years) | 0 |
| Since 2005 (last 20 years) | 1 |
Descriptor
| Attention Deficit… | 1 |
| Check Lists | 1 |
| Cognitive Processes | 1 |
| Comparative Analysis | 1 |
| Drug Therapy | 1 |
| Eating Disorders | 1 |
| Neuropsychology | 1 |
| Pain | 1 |
| Patients | 1 |
| Safety | 1 |
| Scores | 1 |
| More ▼ | |
Source
| Child Psychiatry and Human… | 1 |
Author
| Agaoglu, Belma | 1 |
| Karakaya, Isik | 1 |
| Memik, Nursu Cakin | 1 |
| Sismanlar, Sahika G. | 1 |
| Yildiz, Ozlem | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Evaluative | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkYildiz, Ozlem; Sismanlar, Sahika G.; Memik, Nursu Cakin; Karakaya, Isik; Agaoglu, Belma – Child Psychiatry and Human Development, 2011
The aim of this study was to compare the safety, efficacy, tolerability, and the effects of atomoxetine and OROS-MPH on executive functions in children with ADHD. This study was an open-label study that only included two medication groups. Children were randomized to open-label atomoxetine or OROS-MPH for 12 weeks. Primary efficacy measures were…
Descriptors: Pain, Safety, Attention Deficit Hyperactivity Disorder, Patients
